Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Matrifen 50 microgram/hour Transdermal patch - UK EMC Drug Approval Details

Approvals/UK EMC/Matrifen 50 microgram/hour Transdermal patch

Approved

STANDARD

Matrifen 50 microgram/hour Transdermal patch

Istituto Gentili S.r.l🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 955b76765fa05493
Company: Istituto Gentili S.r.l
Type: Standard

Approval Details

Approval Id: 955b76765fa05493
Drug Approval Emc Name: Matrifen 50 microgram/hour Transdermal patch
Drug Name: Matrifen 50 microgram/hour Transdermal patch
Company Name: Istituto Gentili S.r.l
Company Address: Via S.G., Cottolengo 15, Milan, 20143, Italy
Company Website: https://gentilipharma.com/
Company Telephone: +39 0289132700
Company Medical Info Email: medinfo@gentilipharma.com
Atc Code: N02AB03
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

955b76765fa05493

Type

Standard

Back to UK EMC Approvals